Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-2 immunotherapy in children.

C H Chien1, K H Hsieh

  • 1Department of Pediatrics, National Taiwan University Hospital, Taipei, Republic of China.

Pediatrics
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of individual and partner factors on anxiety and depression in Taiwanese prostate cancer patients: A longitudinal study.

European journal of cancer care·2017
Same author

Experiments in intensity guided range sensing recognition of three-dimensional objects.

IEEE transactions on pattern analysis and machine intelligence·2011
Same author

The frequency of food allergy in Australia and Asia.

Environmental toxicology and pharmacology·2011
Same author

Improved field emission properties of thiolated multi-wall carbon nanotubes on a flexible carbon cloth substrate.

Nanotechnology·2011
Same author

Antiproliferative effects of 2-methoxyestradiol alone and in combination with chemotherapeutic agents on human endometrial cancer cells.

European journal of gynaecological oncology·2009
Same author

Mifepristone acts as progesterone antagonist of non-genomic responses but inhibits phytohemagglutinin-induced proliferation in human T cells.

Human reproduction (Oxford, England)·2009
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
Same journal

Blood Lead Testing Among Children Enrolled in Medicaid.

Pediatrics·2026
Same journal

From Screening to Support: Crafting Social Needs Response Systems That Work for Families.

Pediatrics·2026
Same journal

A Social Care Intervention in Pediatric Practices: A Stepped Wedge Cluster Trial.

Pediatrics·2026
Same journal

Pediatric Cheerleading-Related Head Injuries and the "Double Down" Rule Change.

Pediatrics·2026
See all related articles

Interleukin-2 (IL-2) immunotherapy showed potential in treating childhood diseases and cancers, with observed side effects and immune system modulation. Transient improvements were noted in atopic dermatitis and juvenile rheumatoid arthritis patients.

Area of Science:

  • Pediatric Oncology
  • Immunology
  • Dermatology

Background:

  • Interleukin-2 (IL-2) immunotherapy holds promise for immune-mediated diseases and cancers.
  • Limited pediatric data exists for IL-2 treatment efficacy and safety.

Purpose of the Study:

  • To evaluate the safety and efficacy of IL-2 in a pediatric cohort with various conditions.
  • To assess the immunological changes and clinical responses following IL-2 therapy.

Main Methods:

  • Eleven children and adolescents received intravenous IL-2 (10,000–50,000 U/kg every 8 hours).
  • Patients had hepatocellular carcinoma, hepatoblastoma, atopic dermatitis, or juvenile rheumatoid arthritis.
  • Side effects, immunological markers, and clinical outcomes were monitored.

Related Experiment Videos

Main Results:

  • Common side effects included anorexia, fever, diarrhea, anemia, and hypotension (100% or 82%).
  • Immunologically, natural killer cell numbers and activity increased; IL-2 receptor levels tended to decrease.
  • Clinical responses included remission in one juvenile rheumatoid arthritis patient and transient improvement in atopic dermatitis patients.

Conclusions:

  • IL-2 therapy in children is associated with significant side effects but demonstrates immunomodulatory effects.
  • Transient clinical benefits were observed in atopic dermatitis and juvenile rheumatoid arthritis, warranting further investigation.
  • Safety and efficacy require careful consideration in pediatric populations.